Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 185

1.

A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.

Chen LT, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang WK, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Sameshima H, Kang YK, Boku N.

Gastric Cancer. 2019 Dec 20. doi: 10.1007/s10120-019-01034-7. [Epub ahead of print]

PMID:
31863227
2.

Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial.

Macarulla Mercadé T, Chen LT, Li CP, Siveke JT, Cunningham D, Bodoky G, Blanc JF, Lee KH, Dean A, Belanger B, Wang-Gillam A.

Pancreas. 2020 Jan;49(1):62-75. doi: 10.1097/MPA.0000000000001455.

PMID:
31856081
3.

Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study.

Bang YJ, Li CP, Lee KH, Chiu CF, Park JO, Shan YS, Kim JS, Chen JS, Shim HJ, Rau KM, Choi HJ, Oh DY, Belanger B, Chen LT.

Cancer Sci. 2019 Dec 1. doi: 10.1111/cas.14264. [Epub ahead of print]

4.

Characterization of a Fiber Bundle-Based Real-Time Ultrasound/Photoacoustic Imaging System and Its In Vivo Functional Imaging Applications.

Leng H, Wang Y, Jhang DF, Chu TS, Tsao CH, Tsai CH, Giamundo S, Chen YY, Liao KW, Chuang CC, Ger TR, Chen LT, Liao LD.

Micromachines (Basel). 2019 Nov 27;10(12). pii: E820. doi: 10.3390/mi10120820.

5.

A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma-TCOG T1211 study.

Chiang NJ, Tsai KK, Hsiao CF, Yang SH, Hsiao HH, Shen WC, Hsu C, Lin YL, Chen JS, Shan YS, Chen LT.

Eur J Cancer. 2020 Jan;124:123-130. doi: 10.1016/j.ejca.2019.10.023. Epub 2019 Nov 22.

PMID:
31765987
6.

A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue.

Tsai HJ, Tai JJ, Chen LT, Wu MS, Yeh KH, Lin CW, Wang TE, Wang HP, Yu FJ, Liou JM, Hsiao CF, Cheng TY, Yeh HJ, Ko CW, Chen MJ, Lo GH, Hsu PI, Chang CS, Hwang WS, Chuang SS, Lee HW, Shun CT, Chiu CF, Wang WM, Hsieh CY, Liu TW, Lin JT, Kuo SH, Cheng AL.

Haematologica. 2019 Nov 14. pii: haematol.2019.228775. doi: 10.3324/haematol.2019.228775. [Epub ahead of print] No abstract available.

7.

Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia.

Lin WH, Wu SY, Yeh TK, Chen CT, Song JS, Shiao HY, Kuo CC, Hsu T, Lu CT, Wang PC, Wu TS, Peng YH, Lin HY, Chen CP, Weng YL, Kung FC, Wu MH, Su YC, Huang KW, Chou LH, Hsueh CC, Yen KJ, Kuo PC, Huang CL, Chen LT, Shih C, Tsai HJ, Jiaang WT.

J Med Chem. 2019 Dec 26;62(24):11135-11150. doi: 10.1021/acs.jmedchem.9b01229. Epub 2019 Dec 6.

PMID:
31721578
8.

Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8.

Wang HC, Lin YL, Hsu CC, Chao YJ, Hou YC, Chiu TJ, Huang PH, Tang MJ, Chen LT, Shan YS.

Theranostics. 2019 Sep 23;9(24):7168-7183. doi: 10.7150/thno.36830. eCollection 2019.

9.

Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors.

Hsueh YS, Chang HH, Shan YS, Sun HS, Fletcher JA, Li CF, Chen LT.

Oncogene. 2019 Sep;38(38):6550-6565. doi: 10.1038/s41388-019-0900-9. Epub 2019 Jul 30.

10.

Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer.

Chen LT, Macarulla T, Blanc JF, Mirakhur B, Jong FA, Belanger B, Bekaii-Saab T, Siveke JT.

Cancers (Basel). 2019 Jul 28;11(8). pii: E1068. doi: 10.3390/cancers11081068.

11.

The Epidemiology of Gastric Cancers in the Era of Helicobacter pylori Eradication: A Nationwide Cancer Registry-Based Study in Taiwan.

Chang JS, Kuo SH, Chu PY, Shan YS, Tsai CR, Tsai HJ, Chen LT.

Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1694-1703. doi: 10.1158/1055-9965.EPI-19-0355. Epub 2019 Jul 26.

PMID:
31350264
12.

Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer.

Hsu MC, Tsai YL, Lin CH, Pan MR, Shan YS, Cheng TY, Cheng SH, Chen LT, Hung WC.

J Hematol Oncol. 2019 Jul 19;12(1):79. doi: 10.1186/s13045-019-0769-7.

13.

Identification of phenothiazine as an ETV1‑targeting agent in gastrointestinal stromal tumors using the Connectivity Map.

Yen CC, Chen LT, Li CF, Chen SC, Chua WY, Lin YC, Yen CH, Chen YC, Yang MH, Chao Y, Fletcher JA.

Int J Oncol. 2019 Aug;55(2):536-546. doi: 10.3892/ijo.2019.4829. Epub 2019 Jun 21.

PMID:
31268158
14.

Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: a study protocol.

Chen SH, Tsai HL, Jiang JK, Sung YC, Huang CW, Yeh YM, Chen LT, Wang JY.

BMC Cancer. 2019 Jun 28;19(1):640. doi: 10.1186/s12885-019-5826-7.

15.

Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication.

Hung YH, Hsu MC, Chen LT, Hung WC, Pan MR.

J Clin Med. 2019 Jun 24;8(6). pii: E903. doi: 10.3390/jcm8060903. Review.

16.

Deciphering The Potential Role of Hox Genes in Pancreatic Cancer.

Kuo TL, Cheng KH, Chen LT, Hung WC.

Cancers (Basel). 2019 May 27;11(5). pii: E734. doi: 10.3390/cancers11050734. Review.

17.

Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer.

Weng CC, Hsieh MJ, Wu CC, Lin YC, Shan YS, Hung WC, Chen LT, Cheng KH.

Mol Cancer. 2019 May 20;18(1):96. doi: 10.1186/s12943-019-1023-1.

18.

Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer.

Satoh T, Kang YK, Chao Y, Ryu MH, Kato K, Cheol Chung H, Chen JS, Muro K, Ki Kang W, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Tanimoto M, Chen LT, Boku N.

Gastric Cancer. 2020 Jan;23(1):143-153. doi: 10.1007/s10120-019-00970-8. Epub 2019 May 13.

19.

Novel Insights of Lymphomagenesis of Helicobacter pylori-Dependent Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.

Kuo SH, Wu MS, Yeh KH, Lin CW, Hsu PN, Chen LT, Cheng AL.

Cancers (Basel). 2019 Apr 17;11(4). pii: E547. doi: 10.3390/cancers11040547. Review.

20.

Foreword.

Rocha F, Chen LT.

Hepatobiliary Surg Nutr. 2019 Mar;8(Suppl 1):S1. doi: 10.21037/hbsn.2019.02.12. No abstract available.

Supplemental Content

Loading ...
Support Center